ECG
LHDX

EPIQ Capital Group’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

EPIQ Capital Group’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-725,675
Closed -$80.5K – 55
2022
Q4 		$80.5K Sell
725,675
-13,011,695
-95% -$8.3M 0.05% 47
2022
Q3 		$14.6M Buy
13,737,370
+97,502
+0.7% +$222K 7.7% 6
2022
Q2 		$25.4M Sell
13,639,868
-293,752
-2% -$714K 10.57% 4
2022
Q1 		$49.7M Sell
13,933,620
-62,630
-0.4% -$308K 13.6% 2
2021
Q4 		$121M Buy
13,996,250
+200,067
+1% +$1.27M 21.41% 2
2021
Q3 		$105M Buy
13,796,183
+502,733
+4% +$4.24M 10.84% 3
2021
Q2 		$88.3M Buy
13,293,450
+59,865
+0.5% +$377K 9.22% 3
2021
Q1 		$160M Buy
+13,233,585
New +$262M 17.88% 2

Other funds holding LHDX

EV
Eclipse Ventures Palo Alto, California $39.6M AUM
Simplex Trading
Simplex Trading Chicago, Illinois $3.23B AUM 62.07% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
RA
Resolute Advisors San Francisco, California $242M AUM 52.95% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return